No Data
Fractyl Health (GUTS.US) will release its financial report after the market closes on November 12th.
$Fractyl Health (GUTS.US)$ will release its financial report after market close on November 12th, investors are advised to pay attention. How were the previous performances? $Fractyl Health (GUTS.US)$ had revenue of 0.043 million USD, net income of -17.229 million USD, and EPS of -0.36 USD in 2024/Q2. In 2023/Q3, revenue was 0.036 million USD, net income was -15.747 million USD, and EPS was -0.422227 USD. Futubull reminder: 1. The accounting year division of Hong Kong-listed and US-listed companies
Fractyl Health Unveils Promising Gene Therapy Data
Fractyl Health To Present New Preclinical Data On Sustained Weight Maintenance And Blood Sugar From Its Rejuva RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate At ObesityWeek 2024
Express News | Fractyl Health: Results Show Sustained Maintenance of Weight Loss, Blood Sugar Levels at Week 13 in Dio Mice Given Rjva-001 & Continuing High Fat Diet
Express News | Fractyl Health: Nomination of Rjva-002, a Gip/GLP-1 Dual Agonist, as Its First Pancreatic Gene Therapy Candidate for Obesity
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
No Data
No Data